Annual Report 2001 - The Hospital for Sick Children

More documents

Recommendations

Info

Sung L, Weitzman S, Petric M, King SM: The role of infections of primary hemophagocytic lymphohistiocytosis: Case series and review of the literature. Clinical Infectious Diseases: 2001: 33: 1644-1648. Yeung LTF, King SM, Roberts EA: Mother-toinfant transmission of hepatitis C virus. Hepatology: 2001: 34: 223-229. Books & Book Chapters Blaser S, Jay V, Becker LE, Ford-Jones EL: Neonatal Brain Infections (Chapter 10). In: MRI of the Neonatal Brain (Rutherford, ed). WB Saunders (Harcourt), London, U.K: 2002: 201-224. Lynk AD, Kernested DL, Ford-Jones EL: Care of high-risk children - young infants. In: Infection Control in the Child Care center and Pre-school (5th edition) (Donowitz L, ed). Lippincott Williams & Wilkins, Philadelphia: 2001: 23-30. RESEARCH AND INVESTIGATIONS A cost analysis of paediatric HIV care in Canada: A pilot study. Allen U, King SM, Read SE, Ungar W, Stephens D: Hospital for Sick Children ($15,000 2000 - 2001). A phase III randomized, controlled, primary vaccination study to assess the consistency of 3 production lots of Smithkline Beecham Biologicals combined Measles Mumps Rubella- Varicella Vaccine 208136 (MeMuRu- Oka). Ford-Jones EL, Corporate, multicenter: Glaxo Smith Kline ($10,125 2001 - 2002). A phase III randomized, controlled, primary vaccination study to assess the consistency of 3 production lots of Smithkline Beecham Biologicals combined Measles Mumps Rubella- Varicella Vaccine 208136 (MeMuRu- Oka). Smithkline Beecham Biologicals, Ford- Jones EL (Toronto Vaccine Investigator): Smithkline Beecham Biologicals ($143,000 2000 - 2001). A randomized controlled trial of once daily versus three times daily tobramycin in combination with piperacillin in febrile neutropenic children undergoing bone marrow transplantation. Doyle J, Sung L, Dupuis L, Taddio A, Bliss B, Addollell M, Allen UD: Research Institute, The Hospital for Sick Children ($25,044 2000 - 2001). 34 A randomized, double-blind, controlled study of an increased caloric density infant formula and its effect on growth and nutritional status in HIV-infected infants. Gomez MP, Read SE, McNeil P (Co-PI's, Nassau site): NIH (US funds) ($120,000 2001 - 2002). An HIV risk reduction intervention for incarcerated youth in Canada. Goldberg E, Millson P, Leslie K, Read S, Rivers SE, Wormith D, Meen: OHTN ($600,000 1999 - 2003). An open-label phase I/II study of ABT-378/ritonavir in combination with reverse transcriptase inhibitors in HIV-infected children. Gomez, Read SE, McNeil (co-PI's, Nassau site): Abbott (US Funds) ($60,000 1999 - 2001). Canada AIDS Russia Project. Flannagan W, Read S, Salit I, Major C, Calzavara L: Canadian International Development Agency ($3,200,000 2001 - 2004). Collection of RSV Isolates - please note scientific review complete only - also possible additional $3000 for phase II. Ford-Jones EL and Petric M: Aventis Pasteur ($6,500 2002 - 2003). Do children with acute bronchiolitis need chest radiographs? Schuh S, Dick P, Lalani A, Allen U, Manson D, Babyn P, Stephens D: Physician's Services Incorporated ($108,346 2001 - 2002). Evaluating safety and risk of antiretroviral drug exposure during pregnancy for infants born to HIV positive women in Ontario. King SM, Koren G: Ontario HIV Treatment Network (OHTN) ($175,000 1999 - 2002). Evaluating safety and risk of antiretroviral drug exposure during pregnancy for infants born to HIV positive women in Ontario. King SM, Koren G: Glaxo-wellcome & Biochem- Pharma ($100,000 1999 - 2003). Evaluation of rapid HIV testing in the delivery room. King SM, Guenter D, Remis R, Read SE, Swantee C, Rachlis A, Walmsley S, Gough K, Lefebvre J, Cohen H, Akhoury A, Zlotnick Shaul R: Ontario HIV Treatment Network ($200,000 2002 - 2004). IMPACT (Immunizing monitoring program active). Scheifele D, Halpern D, Ford-Jones EL (local investigator for HSC): Health Canada (administered through Canadian Paediatric Society) ($39,974 2001 - 2002). Implementation and evaluation of RSV prophylaxis in Canada. Upton Allen, HSC RSV Task Force: Abbott Canada ($39,429 2001 - 2002). Low Birth Weight Infants: Epidemiology of colonization with antimicrobial resistant flora at hospital discharge and on follow-up. Matlow A, O'Brien K: The Hospital for Sick Children Seed Grant ($32,640 2001 - 2003). Meningococcal surveillance. Scheifele D, LeSaux N, IMPACT (Ford-Jones EL, member): Canadian Paediatric Society ($3,316 2001 - 2002). New Directions in EBV/PTLD Collaborative Research in Transplant Patients. Allen U, EBV and Associated Viruses Collaborative Research Group: Research Institute, Hospital for Sick Children ($25,000 2002 - 2003). Pneumococcal Disease Surveillance. Scheifele D, IMPACT members (Toronto - Ford- Jones: IMPACT/Canadian Paediatric Society ($2,959 2001 - 2002). Pneumococcal Disease Surveillance. Scheifele D, Halpern S, EL Ford-Jones (local investgator): Health Canada through Canadian Paediatric Society ($3,202 2002 - 2003). Point Prevalence Surveillance Project for Nosocomial Infections within Selected Canadian Health Care Institutions. Matlow A, Gravel D: Health Canada: Canadian Nosocomial Infections Surveillance Program ($3,000 2002 - 2003). Polaris HIV Seroconversion Study. Calzavara (PI), Major C, Myers T, Rachlis A, Read S, Cassol S, Millson P, Logue K, Wallace E, Remis R, McGee F, Corey C, Gough K, Graydon M, Tharao E, Trow R, Crossman C: NHRDP, AIDS Prevention and Community Action Program, Health Canada, Glaxo Wellcome Positive Action Fund ($1,486,456 1998 - 2001).
Polaris HIV Seroconversion Study. Calzavara, Liviana, Major C, Myers T, Rachlis A, Read S, Millson P, Logue K, Wallace E, Remis R, McGee F, Corey P, Gough K, Graydon M, Tharao E, Crossman, C: CIHR ($1,800,000 2001 - 2005). Post-transplant lymphoproliferative disease: a randomized trial of ganciclovir prophylaxis among solid organ transplant recipient. Humar A, Allen UD, Hebert D: The Hospital for Sick Children ($129,174 2000 - 2002). Post-transplant lymphoproliferative disease: clinical trials of ganciclovir prophylaxis among solid organ transplant recipients (parallel track component). Allen U, Humar A, Hebert D and the EBV/PTLD Collaboratrive Research Group: Medimmune & Genesis Biopharmaceuticals ($56,000 2001 - 2002). RCT of conventional amphotericin B versus lipid amphotericin B (AmBisome). Upton A, Bohn D, Parshuram C, Doyle J, Richardson S, Grant R, Harvey E, Gilday D: Fujisawa Canada, Inc. ($521,720 2002 - 2004). Retrospective study to charcaterize the effects of anti-retroviral therapy on infants born to HIV infected mothers. King SM, Arnold S, Degani N: The Physicians' Services Incorporated Foundation ($12,300 1999 - 2001). Risk of hospitalization for RSV lower respiratory infection among infants born between 33-35 weeks' gestation. Allen U, O'Brien K, Simmons B, Newman C: Abbott Canada ($57,044 2001 - 2002). Safety, tolerability and immunogenicity of 3 different formulations of a liquid hexavalent combination vaccine (HR5I) Hib conjugate, recombinant HBsAg, diphtheria toxoid, tetanus toxoid, 5-component acellular perutssis vaccine, and inactivated poliovirus 1, 2, 3) when administered to healthy hepatitis B vaccine naive infants at 2, 4, 6 and 12-14 months. (Protocol 003-01). Merck & Co. Inc., Ford-Jones EL (HSC Vaccine Investigator): Merck Frosst Canada & Co. ($217,420 2001 - 2003). Safety, tolerability and immunogenicity of live attenuated Oka/Merck Varicella vaccine in patients undergoing solid organ transplantation. Allen UD, Ward B, Robinson J, Reymond D, Law B, Moore D, and Canadian site investigators: Merck Frosst Canada ($105,000 1999 - 2002). 35
Page 1 and 2: department of paediatrics The Hospi
Page 3 and 4: department of paediatrics The Hospi
Page 5 and 6: in the recognition of those individ
Page 7 and 8: Division of ADOLESCENT MEDICINE tea
Page 9 and 10: faculty Andrew Redington - Chief, I
Page 11 and 12: 253-261. Siu SC, Colman JM, Sorense
Page 13 and 14: faculty Rosanna Weksberg- Chief, Me
Page 15: esearch investigations A screening
Page 18 and 19: Jasper JD, Goel R, Einarson A, Gall
Page 20 and 21: faculty William Mounstephen - head,
Page 22 and 23: faculty Denis Daneman - Chief, Kusi
Page 24 and 25: full time Stanley Zlotkin, Mary Cor
Page 26: Correlation of non-invasive breath
Page 29 and 30: Chastagner P, Bouffet E, Grill J, K
Page 31 and 32: Waye JS, Eng B, Patterson M, Walker
Page 34 and 35: faculty Chaim Roifman, Adelle Atkin
Page 38 and 39: faculty Keith Tanswell - Chief, Jaq
Page 40 and 41: Pediatrics: 2002: 109: 399-403. Van
Page 42: The continued heavy clinical load a
Page 45 and 46: extrahippocampal epilepsy: 12 pedia
Page 47 and 48: faculty Patricia Parkin - Chief, Ta
Page 49 and 50: neurofibroma. Baruchel S, Parkin P,
Page 51 and 52: faculty Dr. Allan L. Coates - Head,
Page 54 and 55: faculty Rayfel Schneider - Chief, B
Page 56: Kawasaki Disease: How a mouse becom
Page 59 and 60: chief residents: Carolyn Beck MD, Q
Page 61 and 62: divisional
Page 63: For more details on 2001-2002, chec

Annual Report 2001 - The Hospital for Sick Children

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?